DekaBank Deutsche Girozentrale - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$494
-35.7%
60,0000.0%0.00%
-50.0%
Q2 2023$768
-19.6%
60,0000.0%0.00%0.0%
Q1 2023$955
+114.6%
60,000
+99.3%
0.00%
+100.0%
Q4 2022$445
-99.9%
30,1000.0%0.00%
-50.0%
Q3 2022$704,000
+39.4%
30,1000.0%0.00%
+100.0%
Q2 2022$505,000
-45.3%
30,1000.0%0.00%
-50.0%
Q1 2022$923,000
+0.5%
30,100
-1.0%
0.00%0.0%
Q4 2021$918,000
-7.5%
30,400
+2.4%
0.00%
-33.3%
Q3 2021$992,000
-10.5%
29,7000.0%0.00%0.0%
Q2 2021$1,108,000
+4.8%
29,7000.0%0.00%
-25.0%
Q1 2021$1,057,000
-6.6%
29,700
+11.2%
0.00%0.0%
Q4 2020$1,132,00026,7000.00%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,139,380$73,958,0008.86%
Darwin Global Management, Ltd. 782,471$27,050,0005.30%
EcoR1 Capital, LLC 3,429,363$118,553,0005.26%
Foresite Capital Management V, LLC 400,000$13,828,0004.06%
Grace Capital 183,112$6,330,0004.03%
BVF INC/IL 2,873,147$99,325,0003.72%
Casdin Capital, LLC 3,375,058$116,676,0003.48%
Fernwood Investment Management, LLC 185,063$6,398,0002.35%
Alphabet Inc. 1,568,486$54,222,0002.19%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$964,675,0001.67%
View complete list of RELAY THERAPEUTICS INC shareholders